Company Altimmune Inc Nasdaq
Equities
US02155H1014
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Treatments for Various Diseases and Disorders, and Vaccines
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -726.47% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -726.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 29/11/18 |
Director of Finance/CFO | 66 | 30/12/21 | |
Anthony Blandin
CMP | Compliance Officer | - | 31/01/22 |
M. Roberts
CTO | Chief Tech/Sci/R&D Officer | 65 | 30/11/12 |
Bertrand Georges
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/15 |
M. Harris
CTO | Chief Tech/Sci/R&D Officer | 71 | 08/09/19 |
Karen Smith
PRN | Corporate Officer/Principal | - | 31/08/20 |
Andrew Shutterly
AUD | Comptroller/Controller/Auditor | - | 30/09/20 |
56 | - | ||
Raymond Jordt
PRN | Corporate Officer/Principal | 52 | 31/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 31/03/10 |
Mack Gill
BRD | Director/Board Member | 72 | 31/07/04 |
Philip Hodges
BRD | Director/Board Member | 56 | 31/08/03 |
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 29/11/18 |
David Drutz
BRD | Director/Board Member | 86 | 31/12/09 |
Wayne Pisano
BRD | Director/Board Member | 69 | 29/08/18 |
Diane Jorkasky
BRD | Director/Board Member | 72 | 10/05/20 |
Catherine Sohn
BRD | Director/Board Member | 71 | 22/03/23 |
Klaus Schafer
BRD | Director/Board Member | 74 | 30/06/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,902,191 | 70,351,925 ( 99.22 %) | 0 | 99.22 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |